Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Hurley

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
AIDS (London, England)|June 24, 2003
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individualsMichael Louie, Christine Hogan, Arlene Hurley, et al.
The Journal of Infectious Diseases|March 28, 2003
Determining the relative efficacy of highly active antiretroviral therapyMichael Louie, Christine Hogan, Michele Di Mascio, et al.
Journal of Virology|September 13, 2003
Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapyMichael A Poles, Shady Barsoum, Wenjie Yu, et al.
JCI Insight|April 12, 2019
Detection of circulating extracellular mRNAs by modified small-RNA-sequencing analysisKemal M Akat, Youngmin A Lee, Arlene Hurley, et al.
The Journal of Infectious Diseases|August 27, 2002
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccinationMartin Markowitz, Xia Jin, Arlene Hurley, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|June 24, 2003
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individualsMichael Louie, Christine Hogan, Arlene Hurley, et al.
The Journal of Infectious Diseases|March 28, 2003
Determining the relative efficacy of highly active antiretroviral therapyMichael Louie, Christine Hogan, Michele Di Mascio, et al.
Journal of Virology|September 13, 2003
Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapyMichael A Poles, Shady Barsoum, Wenjie Yu, et al.
JCI Insight|April 12, 2019
Detection of circulating extracellular mRNAs by modified small-RNA-sequencing analysisKemal M Akat, Youngmin A Lee, Arlene Hurley, et al.
The Journal of Infectious Diseases|August 27, 2002
Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccinationMartin Markowitz, Xia Jin, Arlene Hurley, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
The Journal of Experimental Medicine|July 25, 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope proteinFlorian Klein, Christian Gaebler, Hugo Mouquet, et al.
Nature|March 17, 2009
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individualsJohannes F Scheid, Hugo Mouquet, Niklas Feldhahn, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Pageof 4